Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Appili Therapeutics Inc T.APLI

Alternate Symbol(s):  APLIF

Appili Therapeutics Inc is a biopharmaceutical company. The company is engaged in novel antibiotic and anti-infective therapies to help patients suffering from serious infections. Its anti-infective portfolio currently includes major programs namely ATI-2307, ATI-1701, ATI-1503, ATI-1501 and Favipiravir.

The Market Herald Price Sensitive
{{currentVideo.title}} {{currentVideo.relativeTime}}
{{currentVideo.storiesTitle}}:
{{story.companySymbol}}
{{story.companySymbol}} {{story.headline}}
< Previous bulletin
Next bulletin >
View modes: 

News Update w Radius Research and $APLI CEO Armand Balboni

News Update: Appili Therapeutics (APLI) w CEO Dr. Armand Balboni  - Develop Leishmaniasis Treatment ATI-1801 - https://www.youtube.com/watch?v=YyE8zLvWApM {^youtubevideo|(width)425...read more

yes, lots of potential and appears to be a well run

company but: * $3.6M they raised will be used almost in full to pay off the previous loan * the interest on the new loan will be at least $1/4 million a year ... and APLI has precious little money on...read more

Webinar Recap w Radius Research & $APLI CEO Armand Balboni

Webinar Recap: Appili Therapeutics (APLI) w CEO Dr. Armand Balboni - Drug Development Focused on Infectious Diseases - Pitch, Deep Dive, and Q&A - https://www.youtube.com/watch?v=xGrmHACzU7c ...read more

Webinar w $APLI CEO Armand Balboni Fri Apr 8 @ 12:30PM ET

Webinar - Appili Therapeutics (APLI) w/ CEO Dr. Armand Balboni Fri, Apr 8 at 12:30pm ET / 9:30am PT Q&A with Radius Research  Register Here - https://us02web.zoom.us/webinar...read more

Appili Therapeutics Announces Non-Convertible Secured Loan

March 29, 2022 07:36 AM Eastern Daylight Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company...read more

Will Lind be converting $3 mil into shares after Mar 18?!!

Will Lind be converting $3 million into shares after Friday March 18?! That would be 10s of millions of shares unloaded on the illiquid APLI market. Scary ... still no update from APLI on this. "...read more

Over US$10 M in New Funding from US Department of Defense

February 28, 2022 07:40 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical...read more

Appili Therapeutics Expands ATI-1501 Commercial Agreement

February 08, 2022 07:17 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical...read more

RE:Isn't this essentially an investment banker's "house play"?

investment bankers running companies equals failure in particular BB : TMD  VIV  APLI  MIMI ATE  GTMS Oh and their great cannabis deal that was a fraud TRST   rate and reply

Isn't this essentially an investment banker's "house play"?

I LOVE it here! JMHO Do you own due diligence always!  rate and reply

INSIDERS

instead of insider buying they issue a stack of $0.13 warrants  not a way to regain credibility  companies controlled by investment bankers is not a great recipe   rate and reply

Positive One Year Challenge Results

November 19, 2021 07:42 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX:APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical company...read more

new drug trial coming in Dec

Preparing for ATI-2307 clinical trial drug product GMP manufacturing runs to be initiated in December 2021. https://ca.finance.yahoo.com/news/appili-therapeutics-reports-financial...read more

Goodbye COVID play on this lol... luckily the majority of my

investment is with Revive Thera (RVV).    rate and reply

IIROC Trade Resumption - APLI

TORONTO, Nov. 12, 2021 /CNW/ - Trading resumes in: Company: Appili Therapeutics Inc. TSX Symbol: APLI All Issues: Yes Resumption (ET): 8:00 AM IIROC can make a decision to...read more

Provides Update on Phase 3 PRESECO Clinical Trial

November 12, 2021 07:19 AM Eastern Standard Time HALIFAX, Nova Scotia--(BUSINESS WIRE)--Appili Therapeutics Inc. (TSX: APLI; OTCQX: APLIF) (the “Company” or “Appili”), a biopharmaceutical...read more

LINK

https://www.precisionvaccinations.com/vaccines/avigan-antiviral-medication  rate and reply

Share swap>

with Aipharma and Aipharma being bought by Aditxt. Things should start to move. Pretty exciting to be apart of something so BIG. There will be a lot money made here so hang on >>>BDM  rate and reply

AVIGAN was approved>

Avigan (Favipiravir) Antiviral News October 28, 2021 - AiPharma owned Global Response Aid and Pharmax announced they have partnered to supply Avigan (Favipiravir) in the UAE. ...read more

Closing of Public Offering of $7,000,220

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES October 14, 2021 09:35 AM Eastern Daylight Time HALIFAX...read more